A	O
Myc	B-ENHANCER
enhancer	I-ENHANCER
cluster	E-ENHANCER
regulates	O
normal	O
and	O
leukaemic	O
haematopoietic	O
stem	O
cell	O
hierarchies	O
.	O


The	O
transcription	O
factor	O
Myc	O
is	O
essential	O
for	O
the	O
regulation	O
of	O
haematopoietic	O
stem	O
cells	O
and	O
progenitors	O
and	O
has	O
a	O
critical	O
function	O
in	O
haematopoietic	O
malignancies	O
.	O


Here	O
we	O
show	O
that	O
an	O
evolutionarily	B-ENHANCER
conserved	I-ENHANCER
region	I-ENHANCER
located	I-ENHANCER
1	I-ENHANCER
.	I-ENHANCER
7	I-ENHANCER
megabases	I-ENHANCER
downstream	I-ENHANCER
of	I-ENHANCER
the	I-ENHANCER
Myc	I-ENHANCER
gene	E-ENHANCER
that	O
has	O
previously	O
been	O
labelled	O
as	O
a	O
'	O
super	B-ENHANCER
-	I-ENHANCER
enhancer	E-ENHANCER
'	O
is	O
essential	O
for	O
the	O
regulation	O
of	O
Myc	O
expression	O
levels	O
in	O
both	O
normal	O
haematopoietic	O
and	O
leukaemic	O
stem	O
cell	O
hierarchies	O
in	O
mice	O
and	O
humans	O
.	O


Deletion	O
of	O
this	O
region	O
in	O
mice	O
leads	O
to	O
a	O
complete	O
loss	O
of	O
Myc	O
expression	O
in	O
haematopoietic	O
stem	O
cells	O
and	O
progenitors	O
.	O


This	O
caused	O
an	O
accumulation	O
of	O
differentiation	O
-	O
arrested	O
multipotent	O
progenitors	O
and	O
loss	O
of	O
myeloid	O
and	O
B	O
cells	O
,	O
mimicking	O
the	O
phenotype	O
caused	O
by	O
Mx1	O
-	O
Cre	O
-	O
mediated	O
conditional	O
deletion	O
of	O
the	O
Myc	O
gene	O
in	O
haematopoietic	O
stem	O
cells	O
.	O


This	O
super	B-ENHANCER
-	I-ENHANCER
enhancer	E-ENHANCER
comprises	O
multiple	O
enhancer	B-ENHANCER
modules	E-ENHANCER
with	O
selective	O
activity	O
that	O
recruits	O
a	O
compendium	O
of	O
transcription	O
factors	O
,	O
including	O
GFI1b	O
,	O
RUNX1	O
and	O
MYB	O
.	O


Analysis	O
of	O
mice	O
carrying	O
deletions	O
of	O
individual	O
enhancer	B-ENHANCER
modules	E-ENHANCER
suggests	O
that	O
specific	O
Myc	O
expression	O
levels	O
throughout	O
most	O
of	O
the	O
haematopoietic	O
hierarchy	O
are	O
controlled	O
by	O
the	O
combinatorial	O
and	O
additive	O
activity	O
of	O
individual	O
enhancer	B-ENHANCER
modules	E-ENHANCER
,	O
which	O
collectively	O
function	O
as	O
a	O
'	O
blood	B-ENHANCER
enhancer	I-ENHANCER
cluster	E-ENHANCER
'	O
(	O
BENC	S-ENHANCER
)	O
.	O


We	O
show	O
that	O
BENC	S-ENHANCER
is	O
also	O
essential	O
for	O
the	O
maintenance	O
of	O
MLL	O
-	O
AF9	O
-	O
driven	O
leukaemia	O
in	O
mice	O
.	O


Furthermore	O
,	O
a	O
BENC	B-ENHANCER
module	E-ENHANCER
,	O
which	O
controls	O
Myc	O
expression	O
in	O
mouse	O
haematopoietic	O
stem	O
cells	O
and	O
progenitors	O
,	O
shows	O
increased	O
chromatin	O
accessibility	O
in	O
human	O
acute	O
myeloid	O
leukaemia	O
stem	O
cells	O
compared	O
to	O
blasts	O
.	O


This	O
difference	O
correlates	O
with	O
MYC	O
expression	O
and	O
patient	O
outcome	O
.	O


We	O
propose	O
that	O
clusters	O
of	O
enhancers	O
,	O
such	O
as	O
BENC	S-ENHANCER
,	O
form	O
highly	O
combinatorial	O
systems	O
that	O
allow	O
precise	O
control	O
of	O
gene	O
expression	O
across	O
normal	O
cellular	O
hierarchies	O
and	O
which	O
also	O
can	O
be	O
hijacked	O
in	O
malignancies	O
.	O
